Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents

BACKGROUND: Virotherapy represents a promising approach for ovarian cancer. In this regard, conditionally replicative adenovirus (CRAd) has been translated to the context of human clinical trials. Advanced design of CRAds has sought to exploit their capacity to induce anti-tumor immunization by conf...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Pastor, Rebeca, Ashshi, Ahmad Mohammad, El-Shemi, Adel Galal, Dmitriev, Igor P., Kashentseva, Elena A., Lu, Zhi Hong, Goedegebuure, S. Peter, Podhajcer, Osvaldo L., Curiel, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376676/
https://www.ncbi.nlm.nih.gov/pubmed/30767772
http://dx.doi.org/10.1186/s13048-019-0493-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376676/
https://www.ncbi.nlm.nih.gov/pubmed/30767772
http://dx.doi.org/10.1186/s13048-019-0493-5

Ejemplares similares